Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China flag China · Delayed Price · Currency is CNY
24.97
+0.01 (0.04%)
At close: Mar 6, 2026

SHE:002287 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,4162,3362,0402,0401,766
Other Revenue
-2.195.554.634.06
2,4162,3382,0452,0451,770
Revenue Growth (YoY)
3.34%14.32%0.02%15.49%19.22%
Cost of Revenue
-419.55324.7325.52269.7
Gross Profit
2,4161,9181,7201,7191,501
Selling, General & Admin
-1,2801,1621,107986.35
Research & Development
-66.7358.6355.0970.82
Other Operating Expenses
1,65334.7632.2629.4728.58
Operating Expenses
1,6531,3821,2531,1921,084
Operating Income
762.95536.7467.52527.71416.45
Interest Expense
--57.79-63.07-56.42-53.43
Interest & Investment Income
-4.1941.9216.96340.33
Currency Exchange Gain (Loss)
--0.01-0.03-0.02-0.02
Other Non Operating Income (Expenses)
-28.78-0.02-1.16-3.56-2.46
EBT Excluding Unusual Items
734.17483.08445.19484.68700.88
Impairment of Goodwill
-----15.77
Gain (Loss) on Sale of Investments
-100.3237.07-37.0820.69
Gain (Loss) on Sale of Assets
--0.320-0.07
Asset Writedown
--0.58-0.3-1.22-0.35
Other Unusual Items
-63.43162.1472.8282.54
Pretax Income
734.17646.24644.41519.2787.91
Income Tax Expense
87.9464.8765.2449.5677.09
Earnings From Continuing Operations
646.23581.37579.18469.64710.83
Minority Interest in Earnings
-0.912.022.95.05
Net Income
646.23582.28581.2472.54715.88
Net Income to Common
646.23582.28581.2472.54715.88
Net Income Growth
10.98%0.19%22.99%-33.99%77.21%
Shares Outstanding (Basic)
544530530530529
Shares Outstanding (Diluted)
544530530530529
Shares Change (YoY)
2.51%0.03%-0.05%0.21%0.12%
EPS (Basic)
1.191.101.100.891.35
EPS (Diluted)
1.191.101.100.891.35
EPS Growth
8.27%0.15%23.05%-34.13%77.01%
Free Cash Flow
-201.31458.5913.29909.35
Free Cash Flow Per Share
-0.380.860.031.72
Dividend Per Share
-0.3800.4800.3900.590
Dividend Growth
--20.83%23.08%-33.90%73.53%
Gross Margin
100.00%82.06%84.12%84.08%84.77%
Operating Margin
31.58%22.96%22.86%25.81%23.52%
Profit Margin
26.75%24.91%28.42%23.11%40.43%
Free Cash Flow Margin
-8.61%22.42%0.65%51.36%
EBITDA
870.95644.7552.96604.13476.77
EBITDA Margin
36.05%27.57%27.04%29.54%26.93%
D&A For EBITDA
10810885.4376.4260.32
EBIT
762.95536.7467.52527.71416.45
EBIT Margin
31.58%22.96%22.86%25.81%23.52%
Effective Tax Rate
11.98%10.04%10.12%9.54%9.78%
Revenue as Reported
-2,3382,0452,0451,770
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.